gracecastuc-079_lung_multiplex next generation sequencing and its effect on molecular oncology
Published 11 years ago • 39 plays • Length 3:37Download video MP4
Download video MP3
Similar videos
-
1:20
gracecastuc093_lung_dr. sequist on multiplex next generation sequencing
-
6:07
who should receive next generation sequencing (ngs)? - 2022 program: targeted therapies forum
-
13:44
gracecast-079_lung-cancer_challenging cases in lung cancer: unresectable locally advanced nsclc
-
4:13
what is next-gen sequencing?
-
3:20
advantages of next generation sequencing in nsclc - 2022 program: targeted therapies forum - english
-
2:50
cancer genetics 101: next generation sequencing - program: patient education ambassadors 2023-24
-
5:58
gracecastuc-017_lung_a promising option for people with the most common lung cancer mutation?
-
2:25
gracecastuc-075_lung_recommending a repeat biopsy with acqd. resistance to targeted therapy
-
10:03
onctalk 2021 - is broad next generation sequencing (ngs) the standard of care?
-
5:09
gracecastuc-013_lung_what should we do for a "mixed response" to lung cancer treatment?
-
1:10
gracecastuc-070_lung_dr. reckamp on "which patients do you test for molecular marker, and for what?"
-
5:42
gracecastuc-006 - which patients with advanced lung cancer should potentially receive local therapy?
-
1:45
gracecastuc-076_lung_utility of molecular marker results in adjuvant setting for early stage nsclc
-
1:38
gracecastuc-049_lung_seek and use molecular marker information in patients with early stage nsclc?
-
5:11
gracecastuc-015_lung_what is the biology of a mixed response in lung cancer?
-
5:16
gracecastuc 126 lung_is it possible to test for biomarkers on a national scale?
-
6:11
gracecastuc-012_lung_the more you seek, the more you find
-
5:39
gracecastuc 127 lung_molecular markers predicting the best chemotherapy to use in lung cancer
-
2:11
gracecastuc-039_lung_how i use molecular marker information in earlier stage nsclc patients